FDA Approves Moderna's RSV Vaccine for Seniors
TL;DR Summary
Moderna has received its second approval for a vaccine targeting respiratory syncytial virus (RSV) infection.
- Moderna wins second approval with vaccine targeting RSV infection Financial Times
- FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product CNBC
- FDA approves Moderna’s mRNA RSV vaccine for older adults CNN
- Moderna secures FDA approval for RSV vaccine mRESVIA FiercePharma
- Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine Yahoo Finance
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
0 min
vs 1 min read
Condensed
86%
111 → 15 words
Want the full story? Read the original article
Read on Financial Times